-
Brainard DM, Seung E, Frahm N, Cariappa A, Bailey CC, Hart WK, Shin HS, Brooks SF, Knight HL, Eichbaum Q, Yang YG, Sykes M, Walker BD, Freeman GJ, Pillai S, Westmoreland SV, Brander C, Luster AD, Tager AM, 2009: Induction of robust cellular and humoral virus-specific adaptive immune responses in human immunodeficiency virus-infected humanized BLT mice[J]. J Virol, 83, 7305-7321. doi: 10.1128/JVI.02207-08
-
Brooks DG, Hamer DH, Arlen PA, Gao L, Bristol G, Kitchen CM, Berger EA, Zack JA, 2003: Molecular characterization, reactivation, and depletion of latent HIV[J]. Immunity, 19, 413-423. doi: 10.1016/S1074-7613(03)00236-X
-
Chung YS, Son JK, Choi B, Joo SY, Lee YS, Park JB, Moon H, Kim TJ, Kim SH, Hong S, Chang J, Kang MS, Kim SJ, 2015: Co-transplantation of human fetal thymus, bone and CD34(+) cells into young adult immunodeficient NOD/SCID IL2Rgamma(null) mice optimizes humanized mice that mount adaptive antibody responses[J]. Clin Immunol, 157, 156-165. doi: 10.1016/j.clim.2015.02.005
-
Covassin L, Jangalwe S, Jouvet N, Laning J, Burzenski L, Shultz LD, Brehm MA, 2013: Human immune system development and survival of non-obese diabetic (NOD)-SCID IL2rgamma(null) (NSG) mice engrafted with human thymus and autologous haematopoietic stem cells[J]. Clin Exp Immunol, 174, 372-388. doi: 10.1111/cei.12180
-
Dinoso JB, Rabi SA, Blankson JN, Gama L, Mankowski JL, Siliciano RF, Zink MC, Clements JE, 2009: A simian immunodeficiency virus-infected macaque model to study viral reservoirs that persist during highly active antiretroviral therapy[J]. J Virol, 83, 9247-9257. doi: 10.1128/JVI.00840-09
-
Evans DT, Silvestri G, 2013: Nonhuman primate models in aids research[J]. Curr Opin HIV AIDS, 8, 255-261. doi: 10.1097/COH.0b013e328361cee8
-
Ganick DJ, Sarnwick RD, Shahidi NT, Manning DD, 1980: Inability of intravenously injected monocellular suspensions of human bone marrow to establish in the nude mouse[J]. Int Arch Allergy Appl Immunol, 62, 330-333. doi: 10.1159/000232530
-
Gruell H, Klein F, 2017: Progress in HIV-1 antibody research using humanized mice[J]. Curr Opin HIV AIDS, 12, 285-293. doi: 10.1097/COH.0000000000000368
-
Hessell AJ, Haigwood NL, 2015: Animal models in HIV-1 protection and therapy[J]. Curr Opin HIV AIDS, 10, 170-176. doi: 10.1097/COH.0000000000000152
-
Honeycutt JB, Wahl A, Archin N, Choudhary S, Margolis D, Garcia JV, 2013: HIV-1 infection, response to treatment and establishment of viral latency in a novel humanized T cell-only mouse (TOM) model[J]. Retrovirology, 10, 121-. doi: 10.1186/1742-4690-10-121
-
Ishikawa F, Yasukawa M, Lyons B, Yoshida S, Miyamoto T, Yoshimoto G, Watanabe T, Akashi K, Shultz LD, Harada M, 2005: Development of functional human blood and immune systems in NOD/SCID/IL2 receptor gamma chain(null) mice[J]. Blood, 106, 1565-1573. doi: 10.1182/blood-2005-02-0516
-
Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, Hioki K, Ueyama Y, Koyanagi Y, Sugamura K, Tsuji K, Heike T, Nakahata T, 2002: NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells[J]. Blood, 100, 3175-3182. doi: 10.1182/blood-2001-12-0207
-
Jiang Q, Zhang L, Wang R, Jeffrey J, Washburn ML, Brouwer D, Barbour S, Kovalev GI, Unutmaz D, Su L, 2008: Foxp3 + CD4 + regulatory T cells play an important role in acute HIV-1 infection in humanized Rag2-/-gammac-/- mice in vivo[J]. Blood, 112, 2858-2868. doi: 10.1182/blood-2008-03-145946
-
Kim KC, Choi BS, Kim KC, Park KH, Lee HJ, Cho YK, Kim SI, Kim SS, Oh YK, Kim YB, 2016: A simple mouse model for the study of human immunodeficiency virus[J]. AIDS Res Hum Retrovir, 32, 194-202. doi: 10.1089/aid.2015.0211
-
King M, Pearson T, Shultz LD, Leif J, Bottino R, Trucco M, Atkinson MA, Wasserfall C, Herold KC, Woodland RT, Schmidt MR, Woda BA, Thompson MJ, Rossini AA, Greiner DL, 2008: A new Hu-PBL model for the study of human islet alloreactivity based on NOD-SCID mice bearing a targeted mutation in the IL-2 receptor gamma chain gene[J]. Clin Immunol, 126, 303-314. doi: 10.1016/j.clim.2007.11.001
-
Kline C, Ndjomou J, Franks T, Kiser R, Coalter V, Smedley J, Piatak M Jr, Mellors JW, Lifson JD, Ambrose Z, 2013: Persistence of viral reservoirs in multiple tissues after antiretroviral therapy suppression in a macaque RT-SHIV model[J]. PLoS ONE, 8, e84275-. doi: 10.1371/journal.pone.0084275
-
Kumar N, Chahroudi A, Silvestri G, 2016: Animal models to achieve an HIV cure[J]. Curr Opin HIV AIDS, 11, 432-441. doi: 10.1097/COH.0000000000000290
-
Lan P, Tonomura N, Shimizu A, Wang S, Yang YG, 2006: Reconstitution of a functional human immune system in immunodeficient mice through combined human fetal thymus/liver and CD34+ cell transplantation[J]. Blood, 108, 487-492. doi: 10.1182/blood-2005-11-4388
-
Li C, Wang HB, Kuang WD, Ren XX, Song ST, Zhu HZ, Li Q, Xu LR, Guo HJ, Wu L, Wang JH, 2017: Naf1 regulates HIV-1 latency by suppressing viral promoter-driven gene expression in primary CD4+ T cells[J]. J Virol, 91, e01830-16.
-
Lu W, Mehraj V, Vyboh K, Cao W, Li T, Routy JP, 2015: CD4:CD8 ratio as a frontier marker for clinical outcome, immune dysfunction and viral reservoir size in virologically suppressed HIV-positive patients[J]. J Int AIDS Soc, 18, 20052-. doi: 10.7448/IAS.18.1.20052
-
Marsden MD, Kovochich M, Suree N, Shimizu S, Mehta R, Cortado R, Bristol G, An DS, Zack JA, 2012: HIV latency in the humanized BLT mouse[J]. J Virol, 86, 339-347. doi: 10.1128/JVI.06366-11
-
McBride JA, Striker R, 2017: Imbalance in the game of T cells: what can the CD4/CD8 T-cell ratio tell us about HIV and health?[J]. PLoS Pathog, 13, e1006624-. doi: 10.1371/journal.ppat.1006624
-
McCune JM, Namikawa R, Kaneshima H, Shultz LD, Lieberman M, Weissman IL, 1988: The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function[J]. Science, 241, 1632-1639. doi: 10.1126/science.2971269
-
McDermott SP, Eppert K, Lechman ER, Doedens M, Dick JE, 2010: Comparison of human cord blood engraftment between immunocompromised mouse strains[J]. Blood, 116, 193-200. doi: 10.1182/blood-2010-02-271841
-
Mosier DE, Gulizia RJ, Baird SM, Wilson DB, 1988: Transfer of a functional human immune system to mice with severe combined immunodeficiency[J]. Nature, 335, 256-259. doi: 10.1038/335256a0
-
Nixon CC, Mavigner M, Silvestri G, Garcia JV, 2017: In vivo models of human immunodeficiency virus persistence and cure strategies[J]. J Infect Dis, 215, S142-S151. doi: 10.1093/infdis/jiw637
-
Satheesan S, Li H, Burnett JC, Takahashi M, Li S, Wu SX, Synold TW, Rossi JJ, Zhou J, 2018: HIV replication and latency in a humanized NSG mouse model during suppressive oral combinational antiretroviral therapy[J]. J Virol, 92, e02118-17. doi: 10.1128/JVI.02118-17
-
Shultz LD, Schweitzer PA, Christianson SW, Gott B, Schweitzer IB, Tennent B, McKenna S, Mobraaten L, Rajan TV, Greiner DL, 1995: Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice[J]. J Immunol, 154, 180-191.
-
Shultz LD, Ishikawa F, Greiner DL, 2007: Humanized mice in translational biomedical research[J]. Nat Rev Immunol, 7, 118-130. doi: 10.1038/nri2017
-
Strowig T, Rongvaux A, Rathinam C, Takizawa H, Borsotti C, Philbrick W, Eynon EE, Manz MG, Flavell RA, 2011: Transgenic expression of human signal regulatory protein alpha in Rag2-/-gamma(c)-/-mice improves engraftment of human hematopoietic cells in humanized mice[J]. Proc Natl Acad Sci U S A, 108, 13218-13223. doi: 10.1073/pnas.1109769108
-
Sun Z, Denton PW, Estes JD, Othieno FA, Wei BL, Wege AK, Melkus MW, Padgett-Thomas A, Zupancic M, Haase AT, Garcia JV, 2007: Intrarectal transmission, systemic infection, and CD4 + T cell depletion in humanized mice infected with HIV-1[J]. J Exp Med, 204, 705-714. doi: 10.1084/jem.20062411
-
Wu X, Liu L, Cheung KW, Wang H, Lu X, Cheung AK, Liu W, Huang X, Li Y, Chen ZW, Chen SM, Zhang T, Wu H, Chen Z, 2016: Brain invasion by CD4(+) T cells infected with a transmitted/founder HIV-1BJZS7 during acute stage in humanized mice[J]. J Neuroimmune Pharmacol, 11, 572-583. doi: 10.1007/s11481-016-9654-0
-
Ye C, Wang W, Cheng L, Li G, Wen M, Wang Q, Zhang Q, Li D, Zhou P, Su L, 2017: Glycosylphosphatidylinositol-anchored anti-HIV scFv efficiently protects CD4 T cells from HIV-1 infection and deletion in hu-PBL mice[J]. J Virol, 91, e10389-16.
-
Zhang L, Su L, 2012: Hiv-1 immunopathogenesis in humanized mouse models[J]. Cell Mol Immunol, 9, 237-244. doi: 10.1038/cmi.2012.7